Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.

Chaft, J. E.,Dunphy, M.,Naidoo, J.,Travis, W. D.,Hellmann, M.,Woo, K.,Downey, R.,Rusch, V.,Ginsberg, M. S.,Azzoli, C. G.,Kris, M. G.; J Thorac Oncol. 2016 Jan 03.

Comparison of CT volumetric measurement with RECIST response in patients with lung cancer.

Hayes, S. A.,Pietanza, M. C.,O'Driscoll, D.,Zheng, J.,Moskowitz, C. S.,Kris, M. G.,Ginsberg, M. S.; Eur J Radiol. 2016 Feb 11.

From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?

Plodkowski, A. J.,Drilon, A.,Halpenny, D. F.,O'Driscoll, D.,Blair, D.,Litvak, A. M.,Zheng, J.,Moskowitz, C. S.,Ginsberg, M. S.; Lung Cancer. 2015 Oct 02.